Kate Rumrill

Kate Rumrill is the current President & CEO at Ablative Solutions. Kate has over 25 years of experience in the medical field, including previous positions as Vice President Global Medical Affairs at Covidien, Senior Director Clinical Affairs at NeoSync, Inc., and Senior Director Clinical Research at Aspect Medical Systems. Kate Rumrill began their career in 1990 as a Research Scientist at Sterling Winthrop Pharmaceuticals before moving to Eli Lilly and Company in 1995, where they eventually became Clinical Plans Manager and Senior Therapeutic Area Manager.

Kate Rumrill attended the State University of New York College at Oswego, where they earned a BS in biology and psychology.

Deborah Schmalz - VP, Clinical & Regulatory, Tim Fischell - Chief Medical Officer, and Sonia Charrier - VP, Global Quality Systems report to Kate Rumrill.